RLI (RLI) Q1 2026 earnings summary

Executive summary

• Q1 2026 began with an 86.0 combined ratio and 3% premium growth, led by the casualty segment and a 15% increase in net investment income compared to Q1 last year.

• Underwriting income reached $58 million, supported by favorable prior-year reserve development and offset by catastrophe losses and increased expenses.

• Operating earnings were $0.83 per share, down from $0.89 last year, while GAAP net earnings were $0.60 per share, impacted by $39 million in unrealized equity losses.

• Comprehensive earnings dropped to $30 million, reflecting $25 million in other comprehensive loss from rising interest rates.

• The business remains disciplined amid increased competition, focusing on rate adequacy, risk selection, and leveraging data and AI for operational efficiency.

Financial highlights

• Net premiums earned grew 3.3% year-over-year to $411.4 million, with casualty up 10% and property down 9%.

• Net investment income rose 15% year-over-year to $42.3 million, contributing meaningfully to results.

• Net realized gains were $10 million; net unrealized losses on equity securities were $39 million.

• Operating cash flow was $43 million, down $60 million from last year due to tax credit purchases, bonuses, and higher paid losses.

• Book value per share increased 2% from year-end 2025 to $19.54 after adjusting for dividends.

Outlook and guidance

• Growth is expected to persist in casualty and transportation, with strong new business pipelines and continued rate increases.

• Management expects continued focus on underwriting profitability over premium growth, with ongoing investments in people and technology.

• Liquidity and capital resources are considered sufficient for the next 12–24 months, with additional capacity available if needed.

• The company remains optimistic for 2026, focusing on underwriting discipline and selective growth amid market volatility.

• Forward-looking statements caution about risk factors that could materially affect future results.